Published 2012
Table of Contents:
“…Contents: Epigenetics -- levels of control -- The patient
cancer journey-multiple impact
points -- Key translational areas for epigenetics -- DNA methylation as
cancer biomarker -- DNA methylation analysis methods -- Epigenetic gene silencing in malignant cells -- CpG methylation and clinical outcome -- Causes of aberrant DNA methylation in
cancer -- Stem cell targets -- EZH2 as a potential anti-
cancer target -- Epigenetic modification as drug targets -- Epigenetic therapies -- DNA methylation versus platinum resistance -- Phase II trial of Decitabine & Carboplatin -- Effects of low doses of DNA-demethylation agents -- Epigenetic therapies challenges.…”
Call Number:
Loading…
Located:
Loading…
Get full text
Series
Electronic
Video